Axcan Pharma Inc.

Axcan Pharma Inc.

February 26, 2007 12:00 ET

Axcan Pharma to Hold Annual General and Special Meeting of Shareholders on February 28, 2007

MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - Feb. 26, 2007) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) announced today that it will host its fiscal 2006 Annual General and Special Meeting of Shareholders on Wednesday, February 28, 2007. The Meeting will be held at the Omni Hotel, 1050 Sherbrooke West, Montreal, Quebec, Canada at 10:00 A.M. (ET). For those who are unable to attend in person, a webcast of the Company's presentation will be available from 30 minutes after the Meeting on the Company's website at

Axcan shareholders of record at the close of business on January 23, 2007, will be entitled to vote upon matters considered at the meeting.

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Senior Director, Investor Relations and Communications
    450-467-2600 ext. 2000